Figure 1.
Figure 1. Enrichment of MSH2–/– CFU after TMZ treatment. Lethally irradiated wild-type mice received transplants of a mixture of 10% MSH2–/– (□) and 90% wild-type (▪) whole bone marrow, followed by treatment 3 weeks later with 80 mg/kg TMZ daily times 3. Bone marrow was harvested 8 weeks after transplantation, and enrichment of MSH2–/– cells was determined by PCR of individual CFUs. There was a significant increase in the proportion of MSH2–/– CFUs recovered from treated versus untreated mice; P < .0001 (Fisher exact test).

Enrichment of MSH2–/– CFU after TMZ treatment. Lethally irradiated wild-type mice received transplants of a mixture of 10% MSH2–/– (□) and 90% wild-type (▪) whole bone marrow, followed by treatment 3 weeks later with 80 mg/kg TMZ daily times 3. Bone marrow was harvested 8 weeks after transplantation, and enrichment of MSH2–/– cells was determined by PCR of individual CFUs. There was a significant increase in the proportion of MSH2–/– CFUs recovered from treated versus untreated mice; P < .0001 (Fisher exact test).

Close Modal

or Create an Account

Close Modal
Close Modal